Mycophenolate mofetil Completed Phase 3 Trials for Scleroderma / Sclerosis, Progressive Systemic / Interstitial Lung Disease (ILD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02896205Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease